Carretero-Barrio, I.; Caniego-Casas, T.; Rosas, M.; Sánchez, M.C.; MartÃnez-Jáñez, N.; Chiva, M.; Sarrió, D.; Moreno-Bueno, G.; Palacios, J.; Pérez-Mies, B.
Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases. Cancers 2023, 15, 1688.
https://doi.org/10.3390/cancers15061688
AMA Style
Carretero-Barrio I, Caniego-Casas T, Rosas M, Sánchez MC, MartÃnez-Jáñez N, Chiva M, Sarrió D, Moreno-Bueno G, Palacios J, Pérez-Mies B.
Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases. Cancers. 2023; 15(6):1688.
https://doi.org/10.3390/cancers15061688
Chicago/Turabian Style
Carretero-Barrio, Irene, Tamara Caniego-Casas, Marta Rosas, MarÃa Concepción Sánchez, Noelia MartÃnez-Jáñez, Miguel Chiva, David Sarrió, Gema Moreno-Bueno, José Palacios, and Belén Pérez-Mies.
2023. "Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases" Cancers 15, no. 6: 1688.
https://doi.org/10.3390/cancers15061688
APA Style
Carretero-Barrio, I., Caniego-Casas, T., Rosas, M., Sánchez, M. C., MartÃnez-Jáñez, N., Chiva, M., Sarrió, D., Moreno-Bueno, G., Palacios, J., & Pérez-Mies, B.
(2023). Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases. Cancers, 15(6), 1688.
https://doi.org/10.3390/cancers15061688